VBG Kuala Lumpur
Translating Vascular Biology to Clinical Practice: Update and issues in lipid management in Asia
June 26, 2009
Translating Vascular Biology to Clinical Practice:
|
 Managing CV risk in diabetes and the metabolic syndromeDavid D. WatersEmeritus Professor in the Department of Medicine University of California, San Francisco VBG -2009 |
 The vulnerable plaque as target for lipid managementRobert J. Chilton, DO, FACCDepartment of Medicine, Division of Cardiology The University of Texas Health Science Center at San Antonio San Antonio, Texas |
 Lipid management in the real world:Lessons and implications for treatmentPeter J. Lansberg MD, PhD Department of Vascular MedicineAcademic Medical Center, Amsterdam VBG 2009 |
 Statins, safety and compliance: Dealing with side effectsPeter J. Lansberg MD, PhD,Department of Vascular Medicine Academic Medical Center, Amsterdam |
 Lipid management: combining statins & fibrates, what are the issues?Robert J. Chilton, DO, FACC,Department of Medicine, Division of Cardiology, The University of Texas Health Science Center at San Antonio, Texas |
 Translating vascular biology to strategies for CV risk preventionJohn E Deanfield, MDProfessor in Cardiology University College London, United Kingdom |
 CV Risk & Lipid managementIssues and opportunities in AsiaDr. David Quek, Pantai Medical Centre, Kuala Lumpur, Malaysia June 2009, PACE - VBG Asia |
 The vulnerable plaque:Target for lipid managementDr. Robert Chilton, The University of Texas Health Science Center, San Antonio, Texas |
 Lipid managementin real world: Lessons and implications for treatmentDr Peter Lansberg Academic Medical Center, Amsterdam, The Netherlands |
CV Disease in AsiaProf deanfield |
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: